Triple Negative Breast Cancer Immunotherapies | Pemborlizumab works in NeoAdjuvant Setting

Saveri Bhattacharya, DO, Thomas Jefferson University, talks about Triple Negative Breast Cancer Immunotherapies | Pemborlizumab works in NeoAdjuvant Setting at Annual Meeting 2018